blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1911747

EP1911747 - Sulfonamide substituted pyrazoline compounds, their preparation and use as CB1 modulators [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  03.04.2009
Database last updated on 19.10.2024
Most recent event   Tooltip03.04.2009Application deemed to be withdrawnpublished on 06.05.2009  [2009/19]
Applicant(s)For all designated states
Laboratorios del Dr. Esteve S.A.
Av. Mare de Déu de Montserrat, 221
08041 Barcelona / ES
[2008/16]
Inventor(s)01 / Buschmann, Helmut H.
Carrer dels Avellaners, 11
08960 Sant Just Desvern-Barcelona / ES
02 / Torrens-Jover, Antonio
Carrer del Racco 8 2[deg] 2a
08221 Tarressa-Barcelona / ES
03 / Mas-Prio, Josep
C/Cal Princep, 39
08191 Rubi-Barcelona / ES
04 / Yenes-Minguez, Susana
Passeig del Terraplé, 71 3[deg] 1a
08570 Molins de Rei-Barcelona / ES
 [2008/16]
Representative(s)Peters, Hajo, et al
Graf von Stosch
Patentanwaltsgesellschaft mbH
Prinzregentenstrasse 22
80538 München / DE
[N/P]
Former [2008/40]Peters, Hajo, et al
Bosch Graf von Stosch Jehle Patentanwaltsgesellschaft mbH Prinzregentenstrasse 22
80538 München / DE
Former [2008/16]Peters, Hajo, et al
Bosch Graf von Stosch Jehle Patentanwaltsgesellschaft mbH Flüggenstrasse 13
80639 München / DE
Application number, filing date06384015.111.10.2006
[2008/16]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP1911747
Date:16.04.2008
Language:EN
[2008/16]
Search report(s)(Supplementary) European search report - dispatched on:EP16.04.2007
ClassificationIPC:C07D231/06, C07D401/12, C07D403/12, C07D405/12, C07D409/12, C07D413/12, C07D417/12, C07D513/04, A61K31/415, A61P3/04
[2008/16]
CPC:
C07D231/06 (EP,US); A61P1/00 (EP); A61P11/00 (EP);
A61P15/00 (EP); A61P19/00 (EP); A61P25/00 (EP);
A61P3/00 (EP); A61P3/04 (EP); A61P35/00 (EP);
A61P37/00 (EP); A61P5/00 (EP); A61P9/00 (EP);
C07D401/12 (EP,US); C07D403/12 (EP,US); C07D405/12 (EP,US);
C07D409/12 (EP,US); C07D413/12 (EP,US); C07D417/12 (EP,US);
C07D513/04 (EP,US) (-)
Designated contracting states(deleted) [2008/52]
Former [2008/16]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  NL,  PL,  PT,  RO,  SE,  SI,  SK,  TR 
TitleGerman:Sulfonamid-substituierte Pyrazolin-derivate, deren Herstellung sowie deren Verwendung als CB1 Modulatoren[2008/16]
English:Sulfonamide substituted pyrazoline compounds, their preparation and use as CB1 modulators[2008/16]
French:Dérivés de pyrazoline substitués par un groupe sulfonamide, leur préparation et leur utlisation comme des modulateurs de CB1[2008/16]
Examination procedure17.10.2008Application deemed to be withdrawn, date of legal effect  [2009/19]
15.12.2008Despatch of communication that the application is deemed to be withdrawn, reason: examination fee not paid in time  [2009/19]
Fees paidPenalty fee
Additional fee for renewal fee
31.10.200803   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[Y]WO2005073197  (SANOFI AVENTIS [FR], et al) [Y] 1-25 * page 1, line 10 - line 12; claim 1 * * page 35, line 9 - line 12 *;
 [Y]WO2005077911  (ESTEVE LABOR DR [ES], et al) [Y] 1-25* example 1; table II *;
 [X]  - MUCCIOLI, G.G. AND LAMBERT, D.M., "Latest advances in cannabinoid receptor antagonists and inverse agonists.", EXPERT OPIN. THER. PATENTS, (2006), vol. 16, no. 10, pages 1405 - 1423, XP002424210 [X] 1-25 * compounds 1,8,20 *

DOI:   http://dx.doi.org/10.1517/13543776.16.10.1405
 [Y]  - LANGE J H M ET AL, "SYNTHESIS, BIOLOGICAL PROPERTIES, AND MOLECULAR MODELING INVESTIGATIONS OF NOVEL 3,4-DIARYLPYRAZOLINES AS POTENT AND SELECTIVE CB1 CANNABINOID RECEPTOR ANTAGONISTS", JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY, US, (2004), vol. 47, no. 3, ISSN 0022-2623, pages 627 - 643, XP001188902 [Y] 1-25 * Rimonabant;;; table 1 *

DOI:   http://dx.doi.org/10.1021/jm031019q
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.